OUR GROWTH STRATEGY
One of the secrets to our success is a repeatable growth strategy that complements our company's strengths and is backed up by a strong organizational structure that can transform it into a sustainable reality.
At EVA Pharma, we base our regional growth strategy on four main imperatives
- Globally accredited Greenfield manufacturing facilities,
- The Development of branded generics.
- Strong sustainable alliances.
- Companies, innovative technologies, and product acquisitions.
WHY PARTNER WITH EVA Pharma?
EVA Pharma believes in the power of partnerships, we believe that getting the right people together catalyzes sustainable success. Our state-of-the-art manufacturing facilities are accredited by different regulatory entities including European authorities, sFDA, UAE, Bahrain, and GCC. Their impressive capabilities include the manufacturing of Solids, Parenterals, Sterile Eye drops, Patches, Liquids, and Semisolids for a wide range of branded generics. This includes more than 160 products in the market and more than 504 products in the pipeline. The strong manufacturing infrastructure is then armed with solid marketing, promotion, and distribution network that spans the region. EVA Pharma also has a notable collection of EU-CTD dossiers available.